John Lambrick
Consigliere Generale presso RMIT University
Profilo
John Lambrick is currently working as the General Counsel at RMIT University.
Previously, he worked as a Non-Executive Director at vivoPharm Pty Ltd.
and as a Partner at Molomby & Molomby.
He completed his graduate degree from the University of Melbourne and his undergraduate degree from Monash University.
Posizioni attive di John Lambrick
| Società | Posizione | Inizio |
|---|---|---|
| RMIT University | Consigliere Generale | - |
Precedenti posizioni note di John Lambrick
| Società | Posizione | Fine |
|---|---|---|
| Molomby & Molomby | Corporate Officer/Principal | - |
vivoPharm Pty Ltd.
 vivoPharm Pty Ltd. BiotechnologyHealth Technology vivoPharm Pty Ltd. provides proprietary preclinical oncology services. It offers integrated service in different disease areas to the biotechnology and pharmaceutical industries. It specializes in conducting studies tailored to guide drug development, starting from compound libraries and ending with a comprehensive set of in vitro and in vivo data and reports, as needed for Investigational New Drug Applications (IND) filing. The company was founded by Ralf Brandt and Sabine Brandt in 2003 and is headquartered in Bundoora, Australia. | Direttore/Membro del Consiglio | - |
Formazione di John Lambrick
| University of Melbourne | Graduate Degree |
| Monash University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
vivoPharm Pty Ltd.
vivoPharm Pty Ltd. BiotechnologyHealth Technology vivoPharm Pty Ltd. provides proprietary preclinical oncology services. It offers integrated service in different disease areas to the biotechnology and pharmaceutical industries. It specializes in conducting studies tailored to guide drug development, starting from compound libraries and ending with a comprehensive set of in vitro and in vivo data and reports, as needed for Investigational New Drug Applications (IND) filing. The company was founded by Ralf Brandt and Sabine Brandt in 2003 and is headquartered in Bundoora, Australia. | Health Technology |
| Molomby & Molomby |
- Borsa valori
- Insiders
- John Lambrick
